지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
The present study was to investigate the effect of naringin, a flavonoid, on the pharmacokinetics of losartan in rats. Pharmacokinetic parameters of losartan in rats were determined after an oral administration of losartan (9 mg/kg) in the presence or absence of naringin (0.5, 2.5 and 10 mg/kg). The pharmacokinetic parameters of losartan were significantly altered by the presence of naringin compared with the control group (given losartan alone). Presence of naringin significantly (p<0.05, 2.5 mg/kg; p<0.01, 10 mg/kg) increased the area under the plasma concentration?time curve (AUC) of losartan by 43.7~63.0% and peak plasma concentration ($C_{max}$) of losartan by 31.7~45.5%. Consequently, the absolute bioavailability (AB) of losartan in the presence of naringin was 43.8~62.9%, which was enhanced significantly (p<0.05, p<0.01) compared to that in the oral control group (22.4%). The relative bioavailability (R.B.) of losartan increased by 1.44- to 1.63-fold in the presence of naringin. However, there was no significant change in the peak plasma concentration ($T_{max}$) and terminal half-life ($t_{1/2}$) of losartan in the presence of naringin. In conclusion, the presence of naringin significantly enhanced the oral bioavailability of losartan, implying that presence of naringin might be mainly effective to inhibit the cytochrome P450 (CYP)3A-mediated metabolism, resulting in reducing gastrointestinal and hepatic first-pass metabilism and Pglycoprotein (P-gp)-mediated efflux of losartan in small intestine. Concurrent use of naringin or naringin-containing dietary supplement with losartan should require close monitoring for potential drug interactions.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
토끼에서 나린진이 틸티아젬과 그대사체, 디아세틸딜티아젬의 생체이용율에 미치는 영향
약학회지
2005 .01
-
흰쥐에서 글리피지드가 로살탄의 약물동태에 미치는 영향
약학회지
2011 .01
-
나린진(Naringin)의 CCl₄에 의한 급성 간독성 보호효과
Environmental Analysis Health and Toxicology
2008 .12
-
흰쥐에서 나린진이 타목시펜의 약물동태에 미치는 영향
한국임상약학회지
2005 .01
-
Effect of Naringin Pretreatment on Bioavailability of Verapamil in Rabbits
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2006 .01
-
Enhanced Tamoxifen Bioavailability after Oral Administration of Tamoxifen in Rats Pretreated with Naringin
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2008 .01
-
Study on Naringin’s Effects on delaying the Progression of Liver Cancer
한국실험동물학회 학술발표대회 논문집
2016 .02
-
토끼에서 나린진이 니모디핀의 생체이용률에 미치는 영향
한국임상약학회지
2008 .01
-
Effect of naringin on lipid metabolism and antithrombotic capacity in rat
한국실험동물학회 학술발표대회 논문집
2008 .11
-
Effects of age on angiotensin II response and antagonistic activity of losartan in rat aorta and liver
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
1996 .01
-
Changes of Bax, Bcl-2, CCR-2, MCP-1, and TGF-β1 genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
Clinical and Experimental Pediatrics
2019 .01
-
Comparison of Inhibitory Effects between Enalapril and Losartan on Adrenal Catecholamine Secretion
Clinical Hypertension
2014 .01
-
Anti-diabetic and anti-obesity potentials of naringin and naringenin
한국실험동물학회 학술발표대회 논문집
2020 .07
-
Inhibitory Effects of Yuzu and Its Components on Human Platelet Aggregation
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
-
Induction of Human Hepatocellular Carcinoma HepG2 Cell Apoptosis by Naringin
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
통풍을 동반한 고혈압 환자에서 요산감소를 위한 losartan과 다른 ARBs간의 임상적 의미 평가
약학회지
2016 .01
-
Losartan Prevents Maladaptive Auditory-Somatosensory Plasticity After Hearing Loss via Transforming Growth Factor-β Signaling Suppression
Clinical and Experimental Otorhinolaryngology
2019 .01
-
사람 장내세균에 의한 폰시린과 나린진의 대사
약학회지
1994 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0